Abiopharma

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001839882-26-040237 <b>Size:</b> 541 KB

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001918704-26-023921 <b>Size:</b> 556 KB

New Form 8-K/A - Repay Holdings Corp <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001193125-26-354037 <b>Size:</b> 1 MB <br />Item 9.01: Financial Statements and Exhibits

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001213900-26-090753 <b>Size:</b> 56 KB

New Form D - Wearable Devices Ltd. <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001213900-26-090752 <b>Size:</b> 17 KB

New Form NT 10-Q - Outlook Therapeutics, Inc. <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001104659-26-097838 <b>Size:</b> 21 KB

New Form DEFA14A - ANAVEX LIFE SCIENCES CORP. <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001731122-26-001083 <b>Size:</b> 901 KB

New Form DEF 14A - HeartCore Enterprises, Inc. <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001493152-26-038740 <b>Size:</b> 2 MB

New Form SCHEDULE 13D/A - Apollomics Inc. <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001193125-26-354020 <b>Size:</b> 613 KB

New Form S-1 - Andersen Group Inc. <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001193125-26-354017 <b>Size:</b> 1 MB

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001918704-26-023920 <b>Size:</b> 872 KB

New Form 424B3 - Backblaze, Inc. <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001140361-26-033378 <b>Size:</b> 172 KB

AtaiBeckley Investor Alert: Kahn Swick &amp; Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AtaiBeckley Inc. - ATAI

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001213900-26-090742 <b>Size:</b> 683 KB

New Form 10-K - Lumentum Holdings Inc. <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001628280-26-057358 <b>Size:</b> 19 MB